Obtaining Technetium-99m-Labeled Glucose Derivatives

The possibility of obtaining and using technetium-99m-labeled glucose derivatives for the diagnosis of malignant tumors by the method of single photon emission computed tomography (SPECT) has been considered. The level of international and domestic developments on this topic has been analyzed. The a...

Full description

Saved in:
Bibliographic Details
Published inAdvanced Materials Research Vol. 1084; pp. 567 - 571
Main Authors Ilyina, Ekaterina A., Stasyuk, Elena S., Rogov, Alexander S., Skuridin, Viktor S.
Format Journal Article
LanguageEnglish
Published Zurich Trans Tech Publications Ltd 01.01.2015
Subjects
Computation
Derivatives
Diagnosis
Glucose
Photon emission
Pilots
Tomography
Tumors
Radiopharmaceutical
Glucose
RPC
Technetium-99m
Online AccessGet full text

Cover

More Information
Summary:The possibility of obtaining and using technetium-99m-labeled glucose derivatives for the diagnosis of malignant tumors by the method of single photon emission computed tomography (SPECT) has been considered. The level of international and domestic developments on this topic has been analyzed. The authors made an attempt to develop pilot batches of lyophilizates on the basis of various glucose derivatives for further obtaining appropriate radiopharmaceuticals (RPC).
Bibliography:Selected, peer reviewed papers from the Conference on Physical-Technical Problems of Nuclear Science, Energy Generation and Power Industry, (PTPAI 2014), June 5-7, 2014, Tomsk, Russia
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISBN:9783038353768
3038353760
ISSN:1022-6680
1662-8985
1662-8985
DOI:10.4028/www.scientific.net/AMR.1084.567